Dimethylformamide → methyl N-[(pent-4-enyloxy)carbonyl]-norleucinate

HRID 388218

Reaktionsgleichung

Reaktionsgleichung von HRID 388218
[CH2:1]=[CH:2][CH2:3][CH:4]([OH:6])C.[C:7](N1C=CN=C1)(N1C=CN=C1)=[O:8].Cl.[CH3:20][O:21][C:22](=[O:29])[C@H:23]([CH2:25][CH2:26][CH2:27][CH3:28])[NH2:24].[CH3:30]N(C=O)C>C(OCC)C>[CH2:4]([O:6][C:7]([NH:24][C@H:23]([C:22]([O:21][CH3:20])=[O:29])[CH2:25][CH2:26][CH2:27][CH3:28])=[O:8])[CH2:3][CH2:2][CH:1]=[CH2:30]

Komponenten

6

Versuchsvorschrift

To a solution of 1-penten-4-ol (0.95 g, 11.0 mmol) in DMF (15 mL) at 0° C. was added carbonyldiimidazole (1.79 g, 11.0 mmol). The reaction mixture was warmed to RT and stirred for 30 minutes. L-norleucine methyl ester hydrochloride (2.0 g, 11.0 mmol) was then added, the reaction mixture was heated to 50° C. and stirred for 15 minutes. Upon cooling, the reaction mixture was diluted with ethyl ether and washed twice with water. The organic layer was dried over Na2SO4, filtered and concentrated. The crude product was purified by silica gel chromatography (gradient elution 10 to 90% EtOAc in hexanes) to afford 2.1 g (74%) methyl N-[(pent-4-en-1-yloxy)carbonyl]-L-norleucinate as a clear oil.

Aufarbeitung

  1. temperaturethe reaction mixture was heated to 50° C.
  2. stirringstirred for 15 minutes
  3. temperatureUpon cooling
  4. washwashed twice with water
  5. dry with materialThe organic layer was dried over Na2SO4
  6. filtrationfiltered
  7. concentrationconcentrated
  8. customThe crude product was purified by silica gel chromatography (gradient elution 10 to 90% EtOAc in hexanes)

Quellen und Nachweise

ORD-Eintrag
ord-10c35e8ddc854de289c08d69cb8c3282
Quelldatensatz
uspto-grants-2013_02
Patentnummer
US08377873B2

Verknüpfte Notizen

Wird geladen…